glp-1 obesity drugs pipeline Can Novo Nordisk's transform treatment? In 5 years, obesity drugs
Description
For information about the UTSW Weight Wellness Program, call 214-645-2800 or request an appointment online
The harmful effect of GLP-1 receptor agonists in rodents but not in primates indicates that the proliferative C-cell effects may be rodent-specific [172]
Davies M, Pieber TR, Hartoft-Nielsen ML, Hansen OKH, Jabbour S, Rosenstock J
[DOI] [PMC free article] [PubMed] [Google Scholar] 487.Harndahl L., Wierup N., Enerback S., Mulder H., Manganiello V.C., Sundler F
